Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1615 1624
This examiner grants 46% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18684872 | HERBICIDAL MALONAMIDES | Non-Final OA | BASF SE |
| 18029028 | STROKE TREATMENT | Non-Final OA | President and Fellows of Harvard College |
| 17923824 | UPCONVERTING NANOPARTICLES | Non-Final OA | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 18499534 | PROCESS AND COMPOSITION MATTER OF NANOPARTICLE FORMULATION FOR SYSTEMIC TREATMENT OF SEPSIS | Final Rejection | Purdue Research Foundation |
| 17252450 | COMPOSITION COMPRISING AT LEAST TWO DIFFERENT ANIONIC SURFACTANTS, NON-IONIC AND AMPHOTERIC SURFACTANTS, AND CATIONIC OR AMPHOTERIC POLYMERS | Non-Final OA | L'OREAL |
| 18559145 | BRAIN-TARGETED ANTIBODY NANOPARTICLE FOR NEURODEGENERATIVE DISEASES THERAPY | Non-Final OA | UNIVERSITY OF SOUTH CAROLINA |
| 18542454 | DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME | Non-Final OA | Axogen Corporation |
| 18254912 | METHOD FOR FABRICATING MICROROBOT FOR DELIVERY OF CELL THERAPY PRODUCT AND MICROROBOT ACCORDING THERETO | Final Rejection | THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 18690241 | METHODS AND COMPOSITIONS TO REDUCE CELLULAR DEPOSITION, AND HYDROCEPHALUS SHUNT FAILURE | Non-Final OA | Wayne State University |
| 18245565 | MULTIPARTICULATE DOSAGE FORMS COMPRISING DEUTETRABENAZINE | Final Rejection | AUSPEX PHARMACEUTICALS, INC. |
| 17416680 | Pest Repellent Composition | Non-Final OA | Kao Corporation |
| 18036676 | ENHANCED FORMULATION STABILIZATION AND IMPROVED LYOPHILIZATION PROCESSES | Non-Final OA | BioNTech SE |
| 17918012 | COMPOSITIONS AND METHODS FOR EMERGENCY RESCUE | Final Rejection | Purdue Pharma L.P. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy